doi: 10.1016/j.clnu.2025.06.011
Among the rare ocular side effects of GLP-1RAs is non-arteritic anterior ischemic optic neuropathy (NAION), which can cause permanent loss of vision, states the report, Glucagon-like Peptide-1 Receptor Agonists and Ocular Health: Guidance for Optometric Practice. The report was first presented at the 2025 Optometry's Meeting | 5th World Congress of Optometry and is meant to provide critical guidance to doctors of optometry treating patients on GLP-1RAs
Who is (and is not) a candidate for DSIP
More Ozempic Gastroparesis Lawsuit Updates November 3, 2025 Update: The federal judge presiding over the GLP-1 MDL granted additional time for both sides to address several major legal and scientific disputes that could influence the direction of the litigation
Serena Williams Just Showed What Over A Year On Weight Loss Medication Looks Like Serena recently said, I think, for me, GLP-1s are a lifetime thing. Serena Williams shared a glimpse at her progress five months after revealing she was taking GLP-1 medication for weight loss
The interplay of oxidative stress and immune dysfunction in Hashimoto's thyroiditis and polycystic ovary syndrome: a comprehensive review
